세계의 반려동물 관절염 시장 규모 분석 : 동물 유형별, 적응증별, 치료법별, 유통 채널별, 지역별, 예측(2022-2032년)

Global Companion Animal Arthritis Market is valued at approximately USD 3.28 billion in 2023 and is anticipated to grow with a steady CAGR of 6.95% over the forecast period 2024-2032. Companion animal arthritis, a progressively degenerative joint condition commonly afflicting dogs and cats, has become a significant clinical and commercial concern in the veterinary landscape. The increasing humanization of pets has shifted the focus of veterinary healthcare from basic needs to comprehensive wellness and longevity, thereby spurring demand for effective arthritis management solutions. From innovative diagnostics and targeted pharmacologics to lifestyle-oriented treatments, the industry is embracing a multidimensional approach. The market is also witnessing a surge in awareness campaigns and education initiatives about early detection and treatment compliance, further enhancing the rate of therapeutic adoption across global veterinary clinics.

Rising pet ownership combined with increased expenditures on pet health are pivotal in fueling the momentum of this market. As more pet parents prioritize their animals' quality of life, there's an evident trend toward advanced arthritic therapies including non-steroidal anti-inflammatory drugs (NSAIDs), regenerative stem cell treatments, and nutritional supplements. Furthermore, the proliferation of pet insurance schemes and wellness plans in North America and Europe significantly reduces the cost burden, making premium care options more accessible. Market players are increasingly collaborating with veterinary research institutions to co-develop novel biologics and biomaterials tailored for chronic joint conditions, creating a dynamic research-to-market pipeline. However, regulatory challenges surrounding new biologic therapies and the high costs associated with advanced treatment modalities may present headwinds to sustained market penetration.

Technological advancements in veterinary orthopedics, alongside personalized treatment regimens, are rapidly transforming therapeutic strategies. Companies are leveraging data analytics and AI-based platforms to monitor arthritis progression and treatment efficacy, allowing for individualized protocols that maximize outcomes. Moreover, the integration of wearable devices for pets that monitor mobility and pain indicators is expected to play a transformative role in early diagnosis and treatment refinement. Alongside these innovations, the nutraceutical segment is booming, with products formulated specifically for joint health gaining traction among consumers looking for preventative solutions. This paradigm shift toward proactive care is expected to continue bolstering revenue streams within the market.

The global landscape for companion animal arthritis solutions is shaped by regional dynamics and infrastructural variances. North America dominates the market, owing to high veterinary healthcare expenditure, a well-established pet insurance ecosystem, and the presence of major industry players. Europe follows closely, driven by robust regulatory frameworks and increasing R&D investment. Meanwhile, Asia Pacific is emerging as a high-growth frontier due to expanding pet populations, rising disposable incomes, and an evolving pet care culture. Countries like China, Japan, and India are experiencing an uptick in demand for advanced veterinary diagnostics and treatments, creating lucrative opportunities for market entrants and established players alike.

Major market player included in this report are:

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Virbac S.A.
• Boehringer Ingelheim International GmbH
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Norbrook Laboratories Ltd.
• Ceva Sante Animale
• Bayer Animal Health
• Merck Animal Health
• Hill's Pet Nutrition Inc.
• Nestle Purina PetCare
• Nutramax Laboratories, Inc.
• Kemin Industries, Inc.
• PetIQ, Inc.

The detailed segments and sub-segment of the market are explained below:

By Animal Type

• Dogs
• Cats

By Indication

• Osteoarthritis
• Hip Dysplasia
• Elbow Dysplasia
• Others

By Treatment

• Pharmaceuticals
  • NSAIDs
  • Corticosteroids
  • Others
• Nutraceuticals
• Physical Therapy
• Surgical

By Distribution Channel

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Companion Animal Arthritis Market Executive Summary

• 1.1. Global Companion Animal Arthritis Market Size & Forecast (2022 - 2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Animal Type
  • 1.3.2. By Indication
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Companion Animal Arthritis Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Pet Owner's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Companion Animal Arthritis Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Escalating Humanization of Pets and Willingness to Invest in Wellness
  • 3.1.2. Rapid Adoption of Pet Insurance and Wellness Plans
  • 3.1.3. Surge in Advanced Biologic and Nutraceutical Therapies
• 3.2. Market Challenges
  • 3.2.1. High Cost of Cutting Edge Treatments and Devices
  • 3.2.2. Regulatory Complexities Surrounding Novel Biologics
• 3.3. Market Opportunities
  • 3.3.1. Integration of AI Enabled Diagnostics and Wearables
  • 3.3.2. Expansion into Emerging APAC and LATAM Pet Markets
  • 3.3.3. Collaborations for Stem Cell and Regenerative Therapies

Chapter 4. Global Companion Animal Arthritis Market Industry Analysis

• 4.1. Porter's Five Forces Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's Model
  • 4.1.7. Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economic
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunities
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Companion Animal Arthritis Market Size & Forecasts by Animal Type 2022 2032

• 5.1. Segment Dashboard
• 5.2. Global Market: Animal Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 5.2.1. Dogs
  • 5.2.2. Cats

Chapter 6. Global Companion Animal Arthritis Market Size & Forecasts by Indication 2022 2032

• 6.1. Segment Dashboard
• 6.2. Global Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 6.2.1. Osteoarthritis
  • 6.2.2. Hip Dysplasia
  • 6.2.3. Elbow Dysplasia
  • 6.2.4. Others

Chapter 7. Global Companion Animal Arthritis Market Size & Forecasts by Region 2022 2032

• 7.1. North America Market
  • 7.1.1. U.S. Market
    • 7.1.1.1. Animal Type breakdown & forecasts, 2022 2032
    • 7.1.1.2. Indication breakdown & forecasts, 2022 2032
  • 7.1.2. Canada Market
• 7.2. Europe Market
  • 7.2.1. UK Market
  • 7.2.2. Germany Market
  • 7.2.3. France Market
  • 7.2.4. Spain Market
  • 7.2.5. Italy Market
  • 7.2.6. Rest of Europe Market
• 7.3. Asia Pacific Market
  • 7.3.1. China Market
  • 7.3.2. India Market
  • 7.3.3. Japan Market
  • 7.3.4. Australia Market
  • 7.3.5. South Korea Market
  • 7.3.6. Rest of APAC Market
• 7.4. Latin America Market
  • 7.4.1. Brazil Market
  • 7.4.2. Mexico Market
  • 7.4.3. Rest of LATAM Market
• 7.5. Middle East & Africa Market
  • 7.5.1. Saudi Arabia Market
  • 7.5.2. South Africa Market
  • 7.5.3. Rest of MEA Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Zoetis Inc.
  • 8.1.2. Elanco Animal Health Incorporated
  • 8.1.3. Virbac S.A.
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Zoetis Inc.
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Elanco Animal Health Incorporated
  • 8.3.3. Virbac S.A.
  • 8.3.4. Boehringer Ingelheim International GmbH
  • 8.3.5. Vetoquinol S.A.
  • 8.3.6. Dechra Pharmaceuticals PLC
  • 8.3.7. Norbrook Laboratories Ltd.
  • 8.3.8. Ceva Sante Animale
  • 8.3.9. Bayer Animal Health
  • 8.3.10. Merck Animal Health
  • 8.3.11. Hill's Pet Nutrition Inc.
  • 8.3.12. Nestle Purina PetCare
  • 8.3.13. Nutramax Laboratories, Inc.
  • 8.3.14. Kemin Industries, Inc.
  • 8.3.15. PetIQ, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes